[HTML][HTML] Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update
R Roskoski Jr - Pharmacological research, 2023 - Elsevier
Owing to the dysregulation of protein kinase activity in many diseases including cancer, this
enzyme family has become one of the most important drug targets in the 21 st century. There …
enzyme family has become one of the most important drug targets in the 21 st century. There …
Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
R Roskoski Jr - Pharmacological research, 2020 - Elsevier
Because genetic alterations including mutations, overexpression, translocations, and
dysregulation of protein kinases are involved in the pathogenesis of many illnesses, this …
dysregulation of protein kinases are involved in the pathogenesis of many illnesses, this …
Properties of FDA-approved small molecule protein kinase inhibitors
R Roskoski Jr - Pharmacological research, 2019 - Elsevier
Because mutations, overexpression, and dysregulation of protein kinases play essential
roles in the pathogenesis of many illnesses, this enzyme family has become one of the most …
roles in the pathogenesis of many illnesses, this enzyme family has become one of the most …
Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update
R Roskoski Jr - Pharmacological research, 2021 - Elsevier
Owing to the dysregulation of protein kinase activity in many diseases including cancer, the
protein kinase enzyme family has become one of the most important drug targets in the 21st …
protein kinase enzyme family has become one of the most important drug targets in the 21st …
Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers
R Roskoski Jr - Pharmacological research, 2019 - Elsevier
The EGFR family is among the most investigated receptor protein-tyrosine kinase groups
owing to its general role in signal transduction and in oncogenesis. This family consists of …
owing to its general role in signal transduction and in oncogenesis. This family consists of …
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
R Roskoski Jr - Pharmacological research, 2019 - Elsevier
Cyclins and cyclin-dependent protein kinases (CDKs) are important proteins that are
required for the regulation and expression of the large number of components necessary for …
required for the regulation and expression of the large number of components necessary for …
[HTML][HTML] Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
R Roskoski Jr - Pharmacological research, 2024 - Elsevier
Owing to the dysregulation of protein kinase activity in many diseases including cancer, this
enzyme family has become one of the most important drug targets in the 21 st century. There …
enzyme family has become one of the most important drug targets in the 21 st century. There …
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
R Roskoski Jr - Pharmacological research, 2016 - Elsevier
Because dysregulation and mutations of protein kinases play causal roles in human
disease, this family of enzymes has become one of the most important drug targets over the …
disease, this family of enzymes has become one of the most important drug targets over the …
Defining a new nomenclature for the structures of active and inactive kinases
V Modi, RL Dunbrack Jr - Proceedings of the National …, 2019 - National Acad Sciences
Targeting protein kinases is an important strategy for intervention in cancer. Inhibitors are
directed at the active conformation or a variety of inactive conformations. While attempts …
directed at the active conformation or a variety of inactive conformations. While attempts …
Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders
R Roskoski Jr - Pharmacological Research, 2022 - Elsevier
The Janus kinase (JAK) family of nonreceptor protein-tyrosine kinases consists of JAK1,
JAK2, JAK3, and TYK2 (Tyrosine Kinase 2). Each of these proteins contains a JAK …
JAK2, JAK3, and TYK2 (Tyrosine Kinase 2). Each of these proteins contains a JAK …